ResearcherArmy Medical UniversityNo recent work listed

Zhi-Peng Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7652-1783; OpenAlex author ID A5100449764. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma. Co-author DOI 10.1097/as9.0000000000000273 ↗
Pumilio RNA-Binding Family Member 1 Plays a Promoting Role on Pancreatic Cancer Angiogenesis. Co-author DOI 10.1155/2022/9202531 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xingxing Su · 2 shared papers, 2022–2023 · strength 0.40
- Paper Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pan… DOI 10.1097/as9.0000000000000273 ↗
- Paper Pumilio RNA-Binding Family Member 1 Plays a Promoting Role on Pancreatic Cancer Angiogenesis. DOI 10.1155/2022/9202531 ↗
Yishi Yang · 2 shared papers, 2022–2023 · strength 0.40
- Paper Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pan… DOI 10.1097/as9.0000000000000273 ↗
- Paper Pumilio RNA-Binding Family Member 1 Plays a Promoting Role on Pancreatic Cancer Angiogenesis. DOI 10.1155/2022/9202531 ↗
Zhiyu Chen · 2 shared papers, 2022–2023 · strength 0.40
- Paper Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pan… DOI 10.1097/as9.0000000000000273 ↗
- Paper Pumilio RNA-Binding Family Member 1 Plays a Promoting Role on Pancreatic Cancer Angiogenesis. DOI 10.1155/2022/9202531 ↗
Haisu Dai · 1 shared paper, 2022 · strength 0.19
- Paper Pumilio RNA-Binding Family Member 1 Plays a Promoting Role on Pancreatic Cancer Angiogenesis. DOI 10.1155/2022/9202531 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.